Intimation for appointment of an internal, secretarial & Cost auditors is attached
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mercury Laboratories reported FY25 revenue of ₹7,510.12 lakhs (vs ₹7,555.90 lakhs last year, a marginal ~0.6% decline), while net profit after tax fell sharply to ₹314.49 lakhs from ₹565.42 lakhs (down ~44%). Q4 FY25 revenue grew ~19% year-on-year to ₹2,065.91 lakhs, but Q4 PAT declined to ₹111.04 lakhs from ₹191.03 lakhs. The board recommended a final dividend of ₹3.50 per share (35%) subject to shareholder approval. Statutory auditors (Naresh & Co.) issued an unmodified opinion. Key board changes include appointment of Mr. Sanjay Patel as Independent Director & Chairman, re-appointment of Mr. Rajendra Shah as MD for 3 years from April 2026, and retirement of Mr. Bharat Mehta. The board also appointed Secretarial, Internal, and Cost Auditors for FY25-26.
Despite flat top-line, a sharp ~44% drop in annual profits signals significant margin pressure and rising costs (employee expenses up ~16%). The 35% dividend provides some return to shareholders, but weakening profitability and a 51% drop in operating cash flow may weigh on near-term sentiment.